Literature DB >> 31565733

Projection of costs of polio eradication compared to permanent control.

Marita Zimmermann1, Brittany Hagedorn1, Hil Lyons1.   

Abstract

Despite increased efforts and spending toward polio eradication, it has yet to be eliminated worldwide. We aimed to project economic costs of polio eradication compared to permanent control. We used historical Financial Resource Requirements from the Global Polio Eradication Initiative, as well as vaccination and population data from publicly available sources to project costs for routine immunization, immunization campaigns, surveillance and lab, technical assistance, social mobilization, treatment, and overhead. We found that cumulative spending for a control strategy would exceed that for an eradication strategy in 2032 (range 2027-2051). Eradication of polio would likely be cost-saving compared to permanent control.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

Keywords:  Budget; Costs; Eradication; Permanent Control; Polio

Year:  2019        PMID: 31565733     DOI: 10.1093/infdis/jiz488

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

Review 1.  Immunity to enteric viruses.

Authors:  Ainsley Lockhart; Daniel Mucida; Roham Parsa
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

2.  Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029.

Authors:  Dominika A Kalkowska; Kimberly M Thompson
Journal:  Risk Anal       Date:  2021-02       Impact factor: 4.000

3.  Economic evaluation of disease elimination: An extension to the net-benefit framework and application to human African trypanosomiasis.

Authors:  Marina Antillon; Ching-I Huang; Kat S Rock; Fabrizio Tediosi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 11.205

4.  Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo.

Authors:  Kat S Rock; Fabrizio Tediosi; Marina Antillon; Ching-I Huang; Ronald E Crump; Paul E Brown; Rian Snijders; Erick Mwamba Miaka; Matt J Keeling
Journal:  Nat Commun       Date:  2022-02-25       Impact factor: 14.919

5.  Polio eradication vaccine investment: how do we ensure polio vaccines are available to keep the world polio-free after transmission of wild poliovirus (wPV) has been interrupted?

Authors:  Amie Batson; Awi Federgruen; Nirmal Kumar Ganguly; Amanda Glassman; Simba Makoni; Stanley Plotkin
Journal:  BMJ Glob Health       Date:  2021-11

6.  Potential Future Use, Costs, and Value of Poliovirus Vaccines.

Authors:  Kimberly M Thompson; Dominika A Kalkowska
Journal:  Risk Anal       Date:  2020-07-09       Impact factor: 4.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.